Dance Costumes Contemporary

New drugs: the FDA is more cautious

The FDA has requested more time to decide whether to approve Ustekinumab , a monoclonal antibody of Johnson & Johnson for the treatment of psoriasis, going against the advice of its experts. ( xagenasalute.it )